SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp ($BULL) is trending amid intense community debate, largely driven by ongoing price depreciation attributed to tax loss harvesting and persistent selling pressure from SPAC-related share overhang. Despite recent inclusion in the Russell 2000/3000 indexes and reported strong revenue growth in its latest quarter, sentiment remains highly polarized. Bulls view the stock as deeply undervalued with significant long-term potential from user growth and international expansion, while bears warn of continued dilution and question the company's valuation.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending after receiving FDA approval for NEREUS (tradipitant), hailed as the first new motion sickness drug in over 40 years. The community is buzzing about its substantial potential to address GLP-1 induced nausea and vomiting, viewing this as a significant market expansion that could drive a revaluation of the company. With additional pipeline catalysts anticipated, many are expressing strong conviction in its future growth, despite some predicting immediate profit-taking.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amid sharp investor division, primarily driven by the recent FDA approval of Novo Nordisk's oral Wegovy pill and speculation around potential distribution partnerships for GLP-1 treatments. While many note the stock's significant drawdown and high short interest as bearish indicators, others view the current valuation as a prime long-term buying opportunity, citing strong fundamentals, institutional accumulation, and the company's expansion into new health verticals and international markets. The community is actively debating whether the current dip sets the stage for a short squeeze or further decline for the direct-to-consumer telehealth provider.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is actively debated amid its significant price volatility, with many investors anticipating potential breakthroughs and new partnerships at the upcoming CES 2026. While some highlight its robust contractual backlog, growing revenues in voice AI, and debt-free status as a compelling buying opportunity, others express deep skepticism regarding management's communication and the stock's recent performance.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is currently trending amidst significant investor frustration as its stock repeatedly hits new all-time lows, fueling widespread community debate over perceived management effectiveness and production execution. Despite recent accolades for its Gravity SUV and strategic partnerships, conversation is heavily focused on the extended interim CEO tenure, potential dilution, and critical concerns about meeting annual vehicle production targets compared to surging EV competitors.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics Holdings is capturing market attention following a proposed business combination with Applied Digital, which would see Applied Digital's cloud GPU business spun off into ChronoScale, an AI compute platform. The potential "AI merger" is fueling fervent discussion among traders, with many anticipating a significant run due to the stock's low float, while others express concerns about potential shareholder dilution.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amid choppy, low-volume trading as market participants grapple with mixed signals from recent Fed minutes regarding future rate policy. Community discussions are sharply divided, with bulls anticipating continued strength towards new highs and bears predicting an imminent correction, particularly as the anticipated "Santa Rally" appears to be largely absent.

Featured in Matt Furies latest book Cortex Vortex as Ratos nemesis. The character is also part of ZOGZ which confirms its real name.  Matt Furie, the artist best known for creating Pepe the Frog, has been working on a new book. The news comes from his editor, who goes by the handle @beuys_on_sale_ on Instagram. In a recent post, the editor hinted at an upcoming project featuring new characters named Gasspas and Rato. Gasspas’s visual appearance can be inferred from the artwork. In one illustration, Gasspas is depicted looming over two rats (Rato and Wat), gazing down at them in a menacing way (an image that has circulated among collectors). This inferred that Gasspas is Ratos nemesis in the new book Cortex Vortex reinforced by community quips that “cats eat rats”. Gasspas debuted as part of ZOGZ, a collection of 111 original NFT character illustrations by Matt Furie launched in May 2023.

Gasspas

Gasspas ($GASS) is currently a hot topic among crypto communities, with many drawing parallels to early Pepe and some associating it with creator Matt Furie. Enthusiasts are actively accumulating due to its low market capitalization, anticipating significant price movements and aiming to 'drop a zero' in its value as part of a broader meme coin rally.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is at the center of investor attention with a highly anticipated regulatory decision for its Cushing's syndrome drug, relacorilant, prompting intense community debate and significant trading volume. Traders are closely watching for an approval or a potential Complete Response Letter, weighing recent sector approvals against CORT's price action and broader pipeline, including its ovarian cancer program, which fuels long-term bullish sentiment despite short-term uncertainty.

Themes ETF Trust - Leverage Shares 2X Long UNH Daily ETF

Leverage Shares 2X Long UNH Daily ETF

UNHG is trending amid widespread investor frustration over a significant price drop that appears decoupled from the performance of its underlying asset, UNH. The community is actively discussing a recent dividend event, which many perceive as fund manipulation or unusual decay rather than a true payout, raising serious concerns about the leveraged ETF's tracking accuracy. This has fueled a broader debate on the legitimacy and reliability of this relatively new 2x leveraged offering, with many advising caution against long-term positions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bitcoin Heads for Fourth Annual Loss: What ETFs May Face in 2026

Bitcoin heads for a fourth annual loss despite institutional support, ETF adoption and Trump backing, raising questions about what 2026 holds for crypto ETFs like IBIT.

<ul class="summary-bullets"><li>According to a report by The Wall Street Journal, FalconX has agreed to acquire crypto ETF manager 21Shares in a cash-and-equity deal.</li><li>The report said the combined company will focus on developing new crypto funds based on derivatives and structured products.</li><li>FalconX’s founder said the merger reflects a fundamental shift in Bitcoin market flows toward traditional investment “wrappers”.</li></ul>Crypto trading platform FalconX has reportedly agreed to acquire 21Shares, one of the largest managers of exchange-traded funds (ETFs) focused on digital assets.According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/finance/currencies/crypto-trading-firm-falconx-to-buy-etf-manager-21shares-f77cb4d3">report</a> by The Wall Street Journal, the deal, financed through a mix of cash and equity, will combine FalconX’s institutional trading network with 21Shares’ expertise in crypto-based investment products. The report did not disclose the financial terms of the transaction.<h2 class="st-heading-2">Focus On Derivatives And Structured Products</h2>The report said the merged company plans to develop new crypto funds centered on derivatives and structured products — a move aimed at broadening access to digital asset exposure through regulated investment vehicles.&nbsp;“Bitcoin flows are now happening through what we call traditional wrappers, and that’s a fundamental shift in market structure,” FalconX founder Raghu Yarlagadda told the publication. He added that the combined business will be able to bring products to market faster.&nbsp;<h2 class="st-heading-2">FalconX Expands U.S. ETF Push Amid Wave Of Crypto M&amp;A</h2>21Shares is already the largest crypto ETP issuer in Europe, with more than $8 billion in assets under management and multiple listings across major exchanges. The firm has been expanding in the U.S. with&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/xrp-solana-etf-approval-sec-decision-crypto-traders/chPzHlRRte">filings</a> for ETFs tied to Bitcoin (BTC), Ethereum (ETH), Dogecoin (DOGE), Solana (SOL), and the FTSE Crypto 10 Index.It partnered with Cathie Wood’s ARK Invest to launch ARK 21Shares Bitcoin ETF (ARKB). ARKB slipped more than 3% in pre-market trade on Wednesday, but retail sentiment on Stocktwits was trending in ‘bullish’ territory as chatter increased to ‘high’ from ‘normal ‘levels.The deal follows a wave of consolidation across the crypto sector. Last week, Ripple&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/ripple-reportedly-doubles-down-on-digital-asset-treasury-plans/ch6siRLR38D">purchased</a> GTreasury, a corporate treasury management software firm, for $1 billion. Coinbase Global also struck a $375 million agreement to acquire Echo, a blockchain capital-raising platform, on Tuesday, according&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/finance/coinbase-strikes-deal-for-crypto-investing-platform-echo-86954fd5">to</a> The Wall Street Journal.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-holds-steady-at-107000-after-750-million-liquidations-jim-cramer-warns/cLG57FsR3qE">Bitcoin Holds Steady At $107,000 After $750 Million Liquidations – Jim Cramer Warns Of ‘Huge Spec Wave’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

FalconX To Acquire 21Shares In Push Toward Crypto ETF Expansion: Report

According to a report by The Wall Street Journal, FalconX has agreed to acquire crypto ETF manager 21Shares in a cash-and-equity deal.

Equity

Can the Uptober Momentum Shift Focus Back to Bitcoin ETFs?

Bitcoin regains its footing with a 14% rally as institutional inflows, Fed cut bets and "Uptober" optimism fuel renewed momentum.

Zacks Investment Ideas feature highlights: Airbnb, Coinbase Global, Circle Group, IBIT, ARKB and JPMorgan Chase

Zacks spotlights Coinbase Global as Brian Armstrong predicts Bitcoin could hit $1 million by 2030, citing new crypto rules and institutional demand.

Bitcoin Hits $125k All-Time High: 9 Must-See Charts

Bitcoin's long-term bullish narrative remains powerfully intact, supported by a scarce supply, seasonal strength, and persistent liquidity. The road to the next major milestone appears well-supported by the metrics that matter most.

Is Brian Armstrong's $1 Million BTC Prediction by 2030 Unrealistic?

While Brian Armstrong's $1 million Bitcoin price target by 2030 may sound sensational, his bull thesis is grounded in powerful market dynamics. Additionally, from a historical and mathematical perspective, Armstrong's prediction is achievable. 

Standard Chartered said on Friday that Bitcoin (BTC) could reach a new record high within a week and continue climbing toward $135,000.In a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://decrypt.co/342805/bitcoin-could-reach-135000-soon-standard-chartered">note</a> cited by Decrypt, Geoff Kendrick, Standard Chartered’s Global Head of Digital Assets Research, stated that Bitcoin has deviated from a historical pattern in which prices typically fell about 18 months after a halving. If that had been the case, the April 2024 halving would have been followed by price weakness now, he noted.&nbsp;<a href="http://stocktwits.com/symbol/BTC.X">Bitcoin’s price</a> was trading at around $120,000 in early morning trade on Friday after a massive rally in the previous session. Retail sentiment around the apex cryptocurrency on Stocktwits improved to ‘extremely bullish’ from ‘bullish’ over the past day, with chatter at ‘high’ levels.Bitcoin’s previous peak of $124,000 in August places the cryptocurrency 3% below that level today. A move toward $135,000 would suggest about a 12% upside. Traders often call October ‘Uptober’ due to the month’s historically strong performance.Kendrick also stated that other factors are affecting Bitcoin’s price. “The shutdown matters this time around,” he wrote. “During the previous Trump shutdown, Bitcoin was in a different place than now, so it did little. However, this year Bitcoin has traded with ‘U.S. government risks’ as best shown by its relationship to U.S. treasury term premium.”Institutional demand is expected to play a larger role in the market. Kendrick said, “Net Bitcoin ETF inflows are now at $58 billion, of which $23 billion has been in 2025. I would expect at least another $20 billion by year-end, a number which would make my $200,000 [BTC] year-end forecast possible.”Bitcoin’s price has gained around 30% this year and nearly doubled over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bnb-leads-altcoin-gains-with-new-all-time-high-as-bitcoin-tops-102-k/chCuSC2R3f6">BNB Leads Altcoin Gains With New All-Time High As Bitcoin Tops $120K In ‘Uptober’ Rally</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Bitcoin symbol on a luminous banner on the BitBase stand during the Mobile World Congress 2023 on March 10, 2023, in Barcelona, Spain. (Photo by Joan Cros/NurPhoto via Getty Images)

Standard Chartered Sees Bitcoin Reaching New Record High In A Week With $135,000 Target: Report

Geoff Kendrick, Standard Chartered’s Global Head of Digital Assets Research, stated that Bitcoin has deviated from a historical pattern in which prices typically fell about 18 months after a halving. 

Cryptocurrency

Will Rate Cuts Fuel Bitcoin ETF Momentum?

Bitcoin gains momentum in September as Fed rate cut bets, dollar weakness and institutional adoption fuel optimism.

The Zacks Analyst Blog Highlights MicroStrategy, Grayscale Bitcoin Trust ETF, iShares Bitcoin Trust, Fidelity Wise Origin Bitcoin Trust, ARK 21Shares Bitcoin ETF and Bitwise Bitcoin ETF

Bitcoin surged past $124K on ETF inflows, corporate adoption, and Fed rate cut bets. Spot ETFs like GBTC, IBIT, FBTC, ARKB, and BITB are in focus.

Bitcoin Hits Record High: ETFs in Focus

Bitcoin's surged past $124K, due to ETF inflows, corporate adoption, and Fed rate cut bets. This put focus on Bitcoin-based ETFs like IBIT and GBTC.

ARKB
ARK 21Shares Bitcoin ETF

Feed

News

Sentiment

Fundamentals

Info

Latest ARKB News

ARKBARK 21Shares Bitcoin ETF